InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Skyler Jay S. Insider active across 3 companies, notably DEXCOM INC. Cumulatively, 7 disclosures have been published. Split: 0 buy · 1 sell. Total volume traded: €2.2m. Activity tracked since 20 May 2021. The latest transaction was disclosed on 6 June 2024 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Skyler Jay S
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
22,500 sharesCommon StockSEC:0001193125-26-036147:0
45,000 shares0Common StockSEC:0000950170-24-070638:0
20,000 shares0Common StockSEC:0001209191-23-035600:0
3,876 shares0Common StockSEC:0001093557-23-000143:0
900 shares0Common StockSEC:0001093557-22-000121:0
6,264 shares@ US$425.4519100.0% of flowCommon StockSEC:0001093557-21-000172:0
822 shares0Common StockSEC:0001093557-21-000147:0
7 of 7 declarations
About Skyler Jay S
SKYLER JAY S is a declarant linked to DEXCOM INC and Applied Therapeutics, Inc., where he is a Director, as well as Applied Therapeutics Inc., where he is a Director. He has 8 filings in total, and across the recent filings we track, sales total 4465259 EUR between 2021-05-25 and 2024-06-07, with no purchases reported.
